Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06255925 · ClinicalTrials.gov registry record · NA
A Strength-Based Employment Maintenance Program for Individuals on the Autism Spectrum
A NA study of Autism, sponsored by Kessler Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06255925: Recruiting NA study of Autism, sponsored by Kessler Foundation.
NCT06255925 is a NA study of Autism that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 30 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06255925, a NA study of Autism, is actively recruiting participants, sponsored by Kessler Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are looking to evaluate how effective a training program that focuses on character strengths may be in improving job maintenance skills in young adults. The investigators are examining the effects of this intervention in young adults who feel they would like to help in improving their satisfaction with work, and in keeping their jobs.
Primary Outcome
Consists of questions answered by parents regarding employment difficulties in their children . Questions of employment valued by yes or no, with yes being valued higher. And amount of hours worked from 0-40, with higher score indicating a better outcome.
Conditions Studied
Interventions
- BEHAVIORAL KF-STRIDE® Into Work!
Study Locations (1)
New Jersey
- Kessler Foundation - East Hanover
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT06255925 shows while recruiting
NCT06255925 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 183-participant average among 104 other Autism trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Autism appearing as the primary indexed condition, and to 1 intervention - of which KF-STRIDE® Into Work! is the first listed.
NCT06255925 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06255925 about?
NCT06255925 is a clinical study titled "A Strength-Based Employment Maintenance Program for Individuals on the Autism Spectrum". The investigators are looking to evaluate how effective a training program that focuses on character strengths may be in improving job maintenance skills in young adults. The investigators are examining the effects of this intervention in young adults who feel they would like to help in improving th...
What is the current status of trial NCT06255925?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-01-01. Estimated completion is 2026-06.
What conditions does trial NCT06255925 study?
This clinical trial studies the following conditions: Autism.
What interventions are being tested in trial NCT06255925?
The interventions under investigation include: KF-STRIDE® Into Work! (BEHAVIORAL).
Who is sponsoring clinical trial NCT06255925?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06255925 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06255925's enrollment target sits among peer trials
30 73rd of 104 higher than 29 of 104 other Autism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
-
Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism
RECRUITING · NA
-
Evaluating Pathways Mutual Gaze Protocol on Social Skills in Young Children Suspected of Autism
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI